Fungi have enormous potential for new antibiotics

Fungi are a potential goldmine for the production of pharmaceuticals. This is shown by researchers at Chalmers University of Technology, who have developed a method for finding new antibiotics from nature's own resources. The findings - which could prove very useful in the battle against antibiotic resistance - were recently published in the journal, Nature Microbiology.

Antibiotics have saved millions of lives since they were discovered in the 1940s. But recently we've had to learn a new term: antibiotic resistance. More and more bacteria are developing their own protection against antibiotics, thereby becoming resistant to treatment. This will lead to simple infections becoming lethal once again. Our need for new antibiotics is urgent.

The first antibiotic to be mass-produced was penicillin, derived from Penicillium fungi. In their quest for new antibiotics, Chalmers researchers sequenced the genomes of nine different types of Penicillium species. And the findings are amazing:

"We found that the fungi have enormous, previously untapped, potential for the production of new antibiotics and other bioactive compounds, such as cancer medicines," says Jens Christian Nielsen, a PhD student at the Department of Biology and Biological Engineering.

He works in a research team led by another Chalmers researcher with almost the same name: Professor Jens Nielsen.

In the study, recently published in the journal, Nature Microbiology, the research group scanned the genomes of 24 different kinds of fungi to find genes responsible for the production of various bioactive compounds, like antibiotics. More than 1000 pathways were discovered, showing immense potential for fungi to produce a large variety of natural and bioactive chemicals that could be used as pharmaceuticals.

In about 90 cases, the researchers were able to predict the chemical products of the pathways. As evidence of this, they followed the production of the antibiotic, yanuthone, and identified new fungi able to produce the compound, but also that some species could produce a new version of the drug.

All in all, the study shows vast potential for fungi, not only in producing new antibiotics but also in enabling more efficient production of existing ones - and maybe also more effective versions of the existing ones.

"It's important to find new antibiotics in order to give physicians a broad palette of antibiotics, existing ones as well as new ones, to use in treatment. This will make it harder for bacteria to develop resistance," explains Jens Christian Nielsen.

"Previous efforts to find new antibiotics have mainly focused on bacteria. Fungi have been hard to study - we know very little of what they can do - but we do know that they develop bioactive substances naturally, as a way to protect themselves and survive in a competitive environment. This made it logical to apply our research tools to fungi."

Researchers now have various paths to follow. One way of moving forward could be to look further at the production of the new yanuthone compound. The Chalmers researchers have also drawn up a map that makes it possible to compare hundreds of genes in the continuous evaluation of bioactive products with potent drugs in sight.

How long it would take to launch new antibiotics on the market is impossible to say.

"Governments need to act. The pharmaceutical industry doesn't want to spend money on new antibiotics, it's not lucrative. This is why our governments have to step in and, for instance, support clinical studies. Their support would make it easier to reach the market, especially for smaller companies. This could fuel production," says Jens Christian Nielsen.

Jens Christian Nielsen, Sietske Grijseels, Sylvain Prigent, Boyang Ji, Jacques Dainat, Kristian Fog Nielsen, Jens Christian Frisvad, Mhairi Workman, Jens Nielsen.
Global analysis of biosynthetic gene clusters reveals vast potential of secondary metabolite production in Penicillium species.
Nature Microbiology, 17044 (2017), doi: 10.1038/nmicrobiol.2017.44.

Most Popular Now

FDA awards 15 grants for clinical trials to stimul…

The U.S. Food and Drug Administration today announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over the next four years to...

A need for bananas? Dietary potassium regulates ca…

Bananas and avocados - foods that are rich in potassium - may help protect against pathogenic vascular calcification, also known as hardening of the arteries. University ...

Amgen and CytomX Therapeutics announce strategic c…

Amgen (NASDAQ:AMGN) and CytomX Therapeutics, Inc., (NASDAQ:CTMX) today announced that the companies have entered into a strategic collaboration in immuno-oncology. The co...

Roche launches NAVIFY Tumor Board solution to prov…

Roche (SIX: RO, ROG; OTCQX:RHHBY), has announced the launch of the NAVIFY Tumor Board solution, a clinical workflow and decision support software that optimises decision-...

Tagrisso granted breakthrough therapy designation …

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Tagrisso (osimertinib) for the 1st-line treatm...

Pfizer launches novel programs to put important su…

Pfizer today unveils enhanced offerings to help patients manage their life with cancer. Pfizer Oncology Together is a first-of-its-kind program for patients taking Pfizer...

Novartis and UC Berkeley collaborate to tackle 'un…

Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pu...

Printed meds could reinvent pharmacies, drug resea…

A technology that can print pure, ultra-precise doses of drugs onto a wide variety of surfaces could one day enable on-site printing of custom-dosed medications at pharma...

Amgen and Simcere announce strategic collaboration…

Amgen (NASDAQ: AMGN) and Simcere Pharmaceutical Group have announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars in China. Th...

IDF and Novo Nordisk launch first-ever global surv…

To mark World Heart Day today, the International Diabetes Federation (IDF) has partnered with Novo Nordisk to launch the first-ever multi-country online survey investigat...

FDA awards six grants for natural history studies …

The U.S. Food and Drug Administration today announced it has awarded six new research grants for natural history studies in rare diseases. The aim of the research is to i...

Indian government needs to do more to tackle risin…

In India, the sale of antibiotics requiring the tightest control and regulation is rising the fastest, according to an analysis by researchers at Queen Mary University of...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]